5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING MAJOR DEPRESSION Application EP-4349407-A2 European Patent Office 10 Apr 2024
Psilocybin and O-acetylpsilocin, salts and solid state forms thereof Grant US-11945832-B2 United States of America 02 Apr 2024
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11939346-B2 United States of America 26 Mar 2024
Nitrilated psilocybin derivatives and methods of using Grant US-11931338-B2 United States of America 19 Mar 2024
Multi-substituent psilocybin derivatives and methods of using Grant US-11918594-B2 United States of America 05 Mar 2024
Tryptamine compositions for enhancing neurite outgrowth Grant US-11911401-B2 United States of America 27 Feb 2024
Tryptamine compositions for enhancing neurite outgrowth Grant US-11896587-B2 United States of America 13 Feb 2024
Prenylated psilocybin derivatives and methods of using Grant US-11891359-B2 United States of America 06 Feb 2024
Glycosylated psilocybin derivatives and methods of using Grant US-11891360-B2 United States of America 06 Feb 2024
N,N-dimethyltryptamine and related psychedelics and uses thereof Grant US-11866408-B2 United States of America 09 Jan 2024
Aminated psilocybin derivatives and methods of using Grant US-11858895-B2 United States of America 02 Jan 2024
Psilocybin and O-acetylpsilocin, salts and solid state forms thereof Grant US-11851452-B2 United States of America 26 Dec 2023
Tryptamine compositions for enhancing neurite outgrowth Grant US-11850254-B2 United States of America 26 Dec 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11851451-B2 United States of America 26 Dec 2023
Aldehyde and ketone derivatives of psilocybin and methods of using Grant US-11845727-B2 United States of America 19 Dec 2023
Antidepressant-psilocybin co-treatment to assist psychotherapy Grant US-11801256-B2 United States of America 31 Oct 2023
COMBINATION OF NITROUS OXIDE AND 5-HT2A RECEPTOR AGONISTS Application WO-2023186963-A1 World Intellectual Property Organisation (WIPO) 05 Oct 2023
Carboxylated psilocybin derivatives and methods of using Grant US-11752130-B2 United States of America 12 Sep 2023
C4-carboxylic acid-substituted tryptamine derivatives and methods of using Grant US-11746087-B1 United States of America 05 Sep 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11738035-B2 United States of America 29 Aug 2023
Combination product for the treatment of neurological and/or psychiatric disorders Grant US-11723894-B2 United States of America 15 Aug 2023
Tryptamine compositions for enhancing neurite outgrowth Grant US-11660305-B2 United States of America 30 May 2023
TREATMENT OF TREATMENT RESISTANT DEPRESSION WITH PSILOCYBIN Application WO-2023086252-A1 World Intellectual Property Organisation (WIPO) 19 May 2023
5-HT2A agonists for use in treatment of depression Grant US-11642336-B2 United States of America 09 May 2023
5-HT2A agonists for use in treatment of depression Grant US-11633390-B2 United States of America 25 Apr 2023
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11629159-B2 United States of America 18 Apr 2023
PHARMACEUTICAL FORMULATION CONTAINING A PSYCHEDELIC SUBSTANCE OBTAINED BY 3D PRINTING BY… Application EP-4159202-A1 European Patent Office 05 Apr 2023
COMBINATION DRUG THERAPIES Application WO-2023036473-A1 World Intellectual Property Organisation (WIPO) 16 Mar 2023
LSD AND PSILOCYBIN DOSE EQUIVALENCE DETERMINATION Application WO-2023012524-A2 World Intellectual Property Organisation (WIPO) 09 Feb 2023
Method for treating anxiety disorders, headache disorders, and eating disorders with… Grant US-11564935-B2 United States of America 31 Jan 2023
ANTIDEPRESSANT-PSILOCYBIN CO-TREATMENT TO ASSIST PSYCHOTHERAPY Application WO-2022259046-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11505564-B2 United States of America 22 Nov 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11447510-B2 United States of America 20 Sep 2022
5-HT RECEPTOR AGONIST TITRATION Application WO-2022189855-A1 World Intellectual Property Organisation (WIPO) 15 Sep 2022
EFFECTS OF MESCALINE AND OF MESCALINE ANALOGS (SCALINES) TO ASSIST PSYCHOTHERAPY Application WO-2022180497-A1 World Intellectual Property Organisation (WIPO) 01 Sep 2022
EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY… Application WO-2022175821-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2022
Crystalline N-methyl tryptamine derivatives Grant US-11332441-B2 United States of America 17 May 2022
5-HT2A agonists for use in treatment of depression Grant US-11246860-B2 United States of America 15 Feb 2022
Methods and compositions comprising 5HT receptor agonists for the treatment of… Application CN-114040767-A China 11 Feb 2022
EXTENDED RELEASE 5-HT RECEPTOR AGONISTS FOR NEUROLOGICAL CONDITIONS Application WO-2022023812-A1 World Intellectual Property Organisation (WIPO) 03 Feb 2022
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11180517-B2 United States of America 23 Nov 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-11149044-B2 United States of America 19 Oct 2021
5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION Application WO-2021089824-A1 World Intellectual Property Organisation (WIPO) 14 May 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10954259-B1 United States of America 23 Mar 2021
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10947257-B2 United States of America 16 Mar 2021
COMPOSITIONS COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR USE IN TREATING… Application WO-2020169851-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020
5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING DEPRESSION Application WO-2020169850-A1 World Intellectual Property Organisation (WIPO) 27 Aug 2020
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and… Grant US-10519175-B2 United States of America 31 Dec 2019